Cell Manufacturing– tag –
-
Miltenyi Biotec’s Global T-Cell Manufacturing Platform Integrates Automated Closed Systems, Cuts Manual Labor by Over 70%, Achieves High Yields
Bioprocess Online Germany Overview Miltenyi Biotec proposes that global scaling of TCR-T cell manufacturing requires a fundamental process redesign, integrating six key production steps into a single automated, closed system. This integr... -
BioProcess International Advocates for Building a Distributed Model for Future Autologous Cell Therapy Manufacturing
BioProcess International Netherlands Overview BioProcess International and IB Communications held a video roundtable proposing the construction of a distributed manufacturing model for the future of autologous cell therapy biomanufacturi... -
BioProcess International Advocates for Distributed Hybrid Model in Autologous Cell Therapy Manufacturing
BioProcess International USA Overview A BioProcess International video roundtable discussed the future of distributed biomanufacturing for autologous cell therapies. With centralized manufacturing struggling to scale and point-of-care mo... -
PAT Revolutionizes Biomanufacturing QA: Raman/NIR Spectroscopy and Inline Probes Enhance Real-Time Monitoring
Technology Networks UK Overview Process Analytical Technology (PAT) is transforming biomanufacturing quality assurance through real-time monitoring. PAT tools, including Raman and NIR spectroscopic sensors, inline probes, and chemometric... -
Denmark Fortifies Biomanufacturing Leadership with $239M AGC Biologics Investment
GeneOnline デンマーク Overview Denmark is rapidly consolidating its position as a global biomanufacturing powerhouse, attracting substantial investment in its advanced infrastructure. AGC Biologics has committed $239 million to significa... -
Hitachi Digital Services Accelerates Life Sciences Digital Transformation with AI and Cloud, Optimizing Drug Discovery and Biomanufacturing
Hitachi Digital Services Japan Overview Hitachi Digital Services is driving digital transformation in life sciences by leveraging AI, data analytics, and cloud platforms to accelerate drug discovery and optimize manufacturing processes. ... -
Bioprocess Analytics Optimizes Biologics Manufacturing with Digital Twins and AI for Predictive Quality Control
World Pharma Today USA Overview This article highlights the strategic application of bioprocess analytics and advanced algorithms to optimize biologics manufacturing. By leveraging real-time data and sophisticated machine learning models... -
Biomanufacturing Quality Control Transforms with Real-time PAT and AI Integration Under FDA ICH Q13 Guidance
Technology Networks UK Overview Process Analytical Technology (PAT) in biomanufacturing is undergoing a paradigm shift from endpoint testing to real-time, in-line measurement, driven by FDA's ICH Q13 guidance on continuous manufacturing,... -
REPROCELL Standardizes and Streamlines PBMC Processing for Multi-Site Clinical Trials with Semi-Automated, Closed Systems and Fully Automated Microfluidic Platforms
REPROCELL Japan Overview A REPROCELL article addresses challenges in Peripheral Blood Mononuclear Cell (PBMC) processing for multi-site clinical trials by introducing innovative solutions to enhance efficiency and standardization. Improv... -
Lonza Unveils Enhanced DNA-to-IND Biologics Manufacturing Offering with 6-Month Timelines, Introducing GS Ori-Go™
PharmaSource Switzerland Overview Lonza has announced an enhanced 'DNA-to-IND' offering for biologics, aiming to achieve IND-readiness for monoclonal antibody programs in as little as six months. This accelerated timeline is supported by...
